Epithelial ovarian cancer: role of pegylated liposomal Doxorubicin in prolonging the platinum-free interval and cancer antigen 125 trends during treatment. [electronic resource]
Producer: 20090811Description: 361-6 p. digitalISSN:- 1525-1438
- CA-125 Antigen -- metabolism
- Carcinoma, Papillary -- drug therapy
- Cohort Studies
- Cystadenocarcinoma, Serous -- drug therapy
- Doxorubicin -- analogs & derivatives
- Drug Resistance, Neoplasm
- Endometrial Neoplasms -- drug therapy
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Ovarian Neoplasms -- drug therapy
- Platinum -- therapeutic use
- Polyethylene Glycols -- therapeutic use
- Prognosis
- Retrospective Studies
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.